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Abstract Oncostatin M, interleukin-1 and the glucocorticoid 
analog, dexamethasone, have been identified as potent stimula- 
tors of ~l-antichymotrypsin production in various cells of epithe- 
lial origin. Although being able to act individually, these factors 
exerted a dramatic increase in ~-antichymotrypsin synthesis 
when administrated in combination. Their stimulatory effect was 
independent of the levels of constitutive synthesis of this inhibitor, 
which was already high in lung- and breast- and low in skin- 
derived epithelial cells. Since ~l-antichymotrypsin controls chy- 
motrypsin-like proteinases which are released during inflamma- 
tion, these data support the concept that local synthesis of this 
inhibitor may be important in reducing tissue damage associated 
with this process. 
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1. Introduction 
matory cytokines, oncostatin M (OSM) and interleukin-1 (IL- 
l), may be the most potent stimulators, especially in combina- 
tion with the glucocorticoid analog dexamethasone (DEX), and 
IL-1 has also been shown to efficiently stimulate another ep- 
ithelial cell line, MCF-7, for Achy production [8]. However, 
interleukin-6 (IL-6), which has been recognized as the principal 
regulator of Achy synthesis in hepatocytes, appeared to have 
little or no effect on MCF-7 and HTB55 cells, respectively. In 
the current study we have evaluated the role of different factors 
associated with inflammation on Achy synthesis in various cells 
of epithelial origin. We chose to use breast adenocarcinoma 
MCF-7, lung adenocarcinoma HTB55, and squamous carci- 
noma Colo-16 as an epithelial cell model for Achy production, 
since these cells express different amounts of this inhibitor. 
Additive, stimulatory effects o fOSM,  IL-1 and DEX on Achy 
synthesis were observed in each cell line examined, raising the 
possibility that epithelial cells are a local source of this inhibitor 
during inflammation. 
Human c~-antichymotrypsin (Achy) is a plasma proteinase 
inhibitor which specifically inactivates chymotrypsin-like pro- 
teinases, including neutrophil cathepsin G and mast cell chy- 
mase [1]. Although its biological role is uncertain, this protein 
appears to be physiologically indispensable since no homozy- 
gous-deficient Achy individuals have been reported [2]. Achy 
heterozygote individuals suffer from disturbances in lung and 
liver function, and some of these abnormalities have been cor- 
related with a protective function for this inhibitor against 
proteolytic attack [3]. Significantly, Achy is known to increase 
rapidly in concentration during tissue injury or malignant pro- 
liferation [4 6] when proteolytic enzymes are believed to be 
released [7]. Because of this response it is important o deter- 
mine the factors which regulate the concentration of Achy in 
tissues and body fluids. While the major source of Achy is liver, 
this inhibitor has also been shown to be expressed in extra- 
hepatic cell types, including cells of epithelial origin [8,9], and 
we have recently demonstrated that the human hepatoma 
HepG2 and human lung epithelial-like cell line HTB55 produce 
comparable amounts of Achy (manuscript submitted). A num- 
ber of factors with hepatocyte stimulating activity have already 
been identified [4,5]; however, much less is known about the 
regulation of Achy expression in epithelial cells. Analysis of 
Achy synthesis by the HTB55 cell line indicates that two inflam- 
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2. Materials and methods 
2.1. Factors 
Human IL-1 was donated by Dr. D. Schenk (Athena Neuroscience 
Inc., San Francisco, CA). Human IL-6 and OSM were generously 
provided by Immunex (Seattle, WA). DEX was purchased from Sigma 
(St. Louis, MO). 
2.2. Cell culture and stimulation 
HTB55 (Calu-3) human lung adenocarcinoma and MCF-7 human 
breast adenocarcinoma cell lines were obtained from the American 
Type Culture Collection (Rockville, MD). The Colo-16 human 
squamous cell carcinoma cell line was a generous gift of Dr. H. Bau- 
mann (Buffalo, NY). Cells were cultured in Eagle's MEM supple- 
mented with 0.1 mM non-essential mino acids solution, 1 mM sodium 
pyruvate, 100 U/ml penicillin G, 100 mg/ml streptomycin (all from 
Gibco, Grand Island, NY) and 10% FBS (Atlanta Biologicals, 
Norcross, GA). For the MCF-7 cell line the medium contained, in 
addition, 10 mg/ml bovine insulin (Gibco). Cells were plated, allowed 
to grow to 70 100% confluency before assay and then treated in serum- 
free medium with the indicated stimulating factors. 
2.3. Northern blot analysis 
Total RNA was isolated by the method of Scherrer and Darnell [10] 
with the modification of Rose-John [11]. RNA was subjected to formal- 
dehyde-agarose g l-electrophoresis [12], transferred to a Hybond-N 
membrane (Amersham, Arlington Hts., IL) according to the manufac- 
ture's instruction, and then hybridized with 32P-labeled probe overnight 
at 65°C in a mixture containing 1M NaC1, 1% SDS and 10% dextran 
sulfate. The probe, a 1.4 kb EcoRI-EcoRI restriction tYagment of 
human Achy cDNA [13], (a generous gift of Dr. H. Rubin, University 
of Pennsylvania) was labeled with the Megaprime Labeling Kit (Amer- 
sham). 
2.4. Determination of Achy concentration 
Culture medium was collected 24 or 48 h after factor(s) addition. In 
the latter case the culture medium was replaced at 24 h by fresh medium 
containing stimulating factors o that the quantitated amount of Achy 
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represents a 24 h incubation period. The amount of accumulated Achy 
was detected by rocket immunoelectrophoresis using polyclonal rabbit 
antibodies against human Achy (Dako, Carpinteria, CA). Purified 
human plasma Achy (kindly provided by Miles Inc., Berkeley, CA) was 
used as a standard. The results were expressed in ng of Achy released 
into the medium by 1 x 10 ~' cells within 24 h. 
2.5. Bios~vnthetic labeling and immunoprecipitation 
Confluent monolayers of Colo-16 cells were treated for 24 h with 
indicated factors. The cells were then rinsed and incubated for 3 h in 
methionine-free medium containing both stimulating factors and 200 
mCi/ml [35S]methionine/cysteine (Tran35S-label) (ICN, Costa Mesa, 
CA). Aliquots of medium were pretreated with preimmune serum and 
Pansorbin (Calbiochem, La Jolla, CA), as previously described [20]. 
The supernatants were then incubated with excess anti-Achy antibody 
in 20 mM Tris-HCl, pH 7.5, 140 mM NaC1, 1% Triton X-100 and 5 mM 
EDTA, overnight at 4°C. Immune complexes were precipitated with 
Pansorbin, washed, released by boiling in Laemmli sample buffer, and 
subjected to 9% SDS-PAGE [14]. Achy was then detected by fluorogra- 
phy as described in [15]. 
3. Results 
We have previously shown that epithelial-like HTB55 cells 
respond to OSM but not to IL-6 in terms of Achy synthesis, 
and that DEX potentiates the effect of OSM (manuscript sub- 
mitted). To find out whether Achy is similarly regulated in 
other epithelial cells, we tested the effect of these factors on 
MCF-7 and Colo-16 cells. MCF-7 cells constitutively express 
relatively high amounts of Achy mRNA,  whereas in Colo-16 
these levels were low (Table 1). As shown in Fig. 1, production 
of Achy in MCF-7 cells was affected by OSM and DEX individ- 
ually, as well as by a combination of DEX with either OSM or 
IL-6. In Colo-16 cells, Achy mRNA levels were substantially 
induced by DEX, while IL-6 and OSM appeared to have no 
Table 1 
Effect of OSM, IL-6, 1L-I or DEX on Achy synthesis ncells of epithe- 
lial origin 
Treatment Achy secretion (ng/ml x l06 cells) 
MCF-7 HTB55 Colo-16 
Control 84 + 43 1170 -+ 400 < 2.5 
OSM 247 + 52 1980 _+ 700 <2.5 
IL-6 71 _+ 18 1430_+430 <2.5 
IL-1 280 _+ 72 1910 _+ 490 <2.5 
OSM + IL-1 675 _+ 163 2490 _+ 680 <2.5 
DEX 198 _+ 41 1400 _+ 480 5 _+ 2 
DEX + OSM 556 _+ l 11 2340 _+ 760 15 + 6 
DEX + IL-6 364 _+ 72 1870 _+ 570 7 _+ 2 
DEX + IL-I 523 _+ 116 2380 _+ 650 7 _+ 2 
DEX + OSM + IL-1 981 _+ 217 3200 _+ 860 19 + 5 
Cells were incubated in serum-free MEM containing 50 ng/ml OSM, 
50 ng/ml IL-6, 100 U/ml IL-I or 10 6 M DEX. Aliquots of cell culture 
media collected at 48 h (from 2448 h incubation period) were analyzed 
by rocket immunoelectrophoresis in order to measure secreted Achy. 
In the case of Colo-16 cells, medium was dialyzed against 25 mM 
amonium bicarbonate, lyophilized, and then dissolved in 1/10 of the 
original volume before immunoelectrophoresis. Mean + S.D. of three 
determinations of two or three separate xperiments are shown. 
effect. However, OSM and to a lesser extent IL-6, in combina- 
tion with DEX markedly up-regulated Achy expression in the 
Colo-16 cells (Fig. 1). 
Since previous studies had demonstrated that IL-I was the 
most potent in inducing Achy synthesis in MCF-7 cells [8], and 
also significantly up-regulated Achy expression i  HTB55 cells, 
we wished to compare the effect of OSM and IL-I. Northern 
blot analysis of RNA extracted from MCF-7 and HTB55 cells 
indicated that these cytokines produced comparable increases 
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Fig. 1. Comparison of the effect of OSM and IL-6 on Achy synthesis nMCF-7 and Colo- 16 cells. Cells were incubated inserum-flee MEM containing 
50 ng/ml IL-6, 50 ng/ml OSM or 10 6 M DEX. At 24 h total cellular RNA was isolated and subjected to Northern blot analysis. The blots were 
photographed to demonstrate equal loading (middle panel) and then hybridized with an Achy probe (upper panel). Samples of MCF-7 medium 
collected at 48 h (from 24-48 h incubation period) were subjected to rocket immunoelectrophoresis using antiserum to Achy. The gel was stained 
with Coomassie blue to demonstrate precipitin lines (bottom panel). 
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Fig. 2. Effect of OSM and IL-1 on Achy production in cells of epithelial origin. Cells were incubated in serum-free MEM supplemented with 50 ng/ml 
OSM, 100 U/ml IL-1 or 10 6 M DEX. (A) Total cellular RNA isolated at 24 h from MCF-7 and HTB55 cells was separated on gels and transferred 
to nylon membranes. The blots were photographed (middle panels) and then hybridized to an Achy probe (upper panels). Samples of MCF-7 and 
HTB55 media collected at 48 h (from 2,~48 h incubation period) were subjected to rocket immunoelectrophoresis u ng antiserum to Achy (bottom 
panels). (B) At 21 h Colo- 16 cells were subjected to radiolabeling for 3 h. Aliquots of culture medium were immunoprecipitated with human anti-Achy. 
lmmunoprecipitates were then subjected to 9% SDS-PAGE followed by fluorography. 
in Achy levels (Fig. 2A). The effect of OSM together with 1L-l 
was additive and strongly enhanced by DEX. These observa- 
tions were confirmed by analysis of the amount of secreted 
Achy. In contrast to both of the adenocarcinoma cell lines 
tested, the additive effect of OSM and IL-1 in Colo-16 cells was 
observed only in the presence of DEX. This was demonstrated 
by an increase in accumulation of newly synthesized Achy (Fig. 
2B). Synthesis of Achy in Colo-16 cells determined by rocket 
immunoelectrophoresis just reached the limits of detection in 
response to DEX and appeared to be slightly up-regulated 
when either IL-I or IL-6 were added (Table 1). Neither OSM 
nor |L- I ,  alone or together, were able to significantly increase 
the amount of secreted Achy (Fig. 2B). The effect of the cytok- 
ines given together with DEX is summarized in Table 1. Note 
that the increase in levels of secreted Achy resulting from OSM 
and DEX addition paralleled the changes described in Fig. 1B 
at mRNA levels. The faster migrating bands shown in Fig. 2B 
most likely represent free [35S]methionine/cysteine, since in con- 
trast to slower migrating bands they were also detected when 
preimmune serum was used (data not shown). 
Because the effect of tested cytokines was most evident in 
MCF-7 cells, this line was chosen to study Achy regulation by 
OSM and IL-1 in the absence of DEX in detail. As shown in 
Fig. 3, the up-regulating effect of these factors on Achy synthe- 
sis reached a maximum at 50 ng/ml OSM and 100 U/ml IL-1 
and did not change significantly when higher concentrations 
were tested. As little as 1 U/ml IL-1 was able to stimulate Achy 
synthesis when acting in concert with OSM, whereas at least 10 
ng/ml OSM appeared to be necessary to observe an additive 
effect with IL-1. 
4. Discussion 
During the host response to tissue injury or inflammation 
there is a dramatic increase in the plasma concentration of 
several proteins, including Achy, all of which are referred to as 
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Fig. 3. Dose-dependent stimulation ofAchy synthesis in MCF-7 cells treated with OSM and IL-1. Cells were incubated inserum-free MEM containing 
indicated amounts of OSM and IL-1. At 24 h, medium was collected and total cellular RNA extracted. RNA was then subjected to Northern blot 
analysis. The blots were photographed (middle panel) and hybridized to an Achy probe (upper panel). Achy accumulated in culture medium was 
demonstrated byrocket immunoelectrophoresis (bottom panel). 
acute-phase proteins (APP). Over the past several years a num- 
ber of factors capable of stimulating production of these APP 
in hepatocytes have been identified. These include IL-6, IL-6- 
related cytokines (OSM, leukemia inhibitory factor, inter- 
leukin- l l ,  cilary neurotrophic factor), IL-1, tumor necrosis 
factor-or and glucocorticoids [4]. Most of these factors were 
examined as potential stimulators of Achy synthesis in lung- 
derived HTB55 cells, and OSM as well as IL-1 appeared to play 
the most important role in regulation of expression of this 
inhibitor (manuscript submitted). A few cytokines and steroid 
hormones were also tested for their effect on synthesis of Achy 
in breast- derived MCF-7 cells, of which IL-1 caused the most 
dramatic increase [8]. These observations led us to investigate 
the possibility that epithelial cells of different origin can re- 
spond to OSM and IL-1 in terms of Achy synthesis. Indeed, in 
all three epithelial cell lines tested production of Achy was 
significantly up-regulated by both cytokines, although in the 
case of keratinocyte-like Colo-16 cells DEX was required to 
observe an effect. 
A number of cell lines originating from the epithelium have 
been shown to produce Achy [9,16]. This inhibitor has also been 
detected in normal and dysplastic epithelial tissue, including 
those from lung and breast [17]. Synthesis of Achy by epithelial 
cells indicates that control of the levels of this inhibitor in 
specific organs could be critical for reducing tissue proteolysis. 
In lung- and breast-derived pithelial cells the already relatively 
high levels of Achy were elevated several times by OSM, IL-1 
and DEX, especially when they were used in combination. The 
reason why epithelial cells are particularly responsive to these 
factors is unknown, but other observations support heir influ- 
ence on this tissue. For instance, lung, breast, as well as several 
other cells of epithelial origin have been shown to bind signifi- 
cant amounts of OSM [18]. Since OSM and IL-1 are secreted 
by host defense effector cells [19-22], up-regulation of Achy 
expression in epithelium ay occur during inflammation. Sig- 
nificantly, neutrophil cathepsin G and mast cell chymase, the 
enzymes controlled by Achy, have been suggested to be the 
major components of the inflammatory response in skin and 
lung [2]. For these reasons it seems likely that the local regula- 
tion of Achy synthesis by inflammatory factors is important in 
the maintenance of a proper proteinase-proteinase inhibitor 
equilibrium in tissues. 
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